Skip to main content
Premium Trial:

Request an Annual Quote

Roche Licenses Real-Time PCR Tools to Takara Bio

NEW YORK (GenomeWeb News) – Roche Diagnostics has licensed fluorescent dye and melting curve analysis technology to Takara Bio for real-time PCR applications, Roche said today.

Under the agreement, Takara has obtained a non-exclusive license to use SYBR Green I technology and melting curve analysis for use on instruments in Japan, and a worldwide license to use the technology in kits for research applications.

Financial terms of the agreement were not disclosed.

In cooperation with Idaho Technology, Roche has licensed this intellectual property portfolio to several companies, including Qiagen, Thermo Fisher Scientific, and Kapa Biosystems.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.